| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.097 | 0.09 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.098 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.043 | 0.4 |